Ajanta Pharma Ltd. - Research Center
532331 AJANTPHARM Group (A) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Jun' 23 | Mar' 23 | Dec' 22 | Sep' 22 | Jun' 22 | |
|---|---|---|---|---|---|
| Sales | 1,014.58 | 848.86 | 874.89 | 837.23 | 850.29 |
| Operating profit | 276.90 | 144.53 | 159.41 | 160.73 | 186.31 |
| Interest | 0.75 | 1.21 | 2.68 | 0.71 | 0.63 |
| Gross profit | 307.61 | 180.07 | 187.24 | 238.39 | 221.10 |
| EPS (Rs) | 16.78 | 9.28 | 9.64 | 13.01 | 11.70 |
Quarterly
results in details
| Jun' 23 | Mar' 23 | Dec' 22 | Sep' 22 | Jun' 22 | |
|---|---|---|---|---|---|
| Other income | 31.46 | 36.75 | 30.51 | 78.37 | 35.42 |
| Stock adjustment | 34.40 | -6.03 | -46.15 | -1.90 | 32.09 |
| Raw material | 217.81 | 231.89 | 246.01 | 205.41 | 195.05 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 196.30 | 207.06 | 175.53 | 170.90 | 166.92 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 289.17 | 271.41 | 340.09 | 302.09 | 269.92 |
| Provisions made | - | - | - | - | - |
| Depreciation | 32.24 | 32.11 | 32.29 | 31.80 | 30.75 |
| Taxation | 63.33 | 30.75 | 30.99 | 39.41 | 39.98 |
| Net profit / loss | 212.04 | 117.21 | 123.96 | 167.18 | 150.37 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 25.27 | 25.27 | 25.71 | 25.71 | 25.71 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 27.29 | 17.03 | 18.22 | 19.20 | 21.91 |
| GPM (%) | 29.41 | 20.33 | 20.68 | 26.04 | 24.96 |
| NPM (%) | 20.27 | 13.23 | 13.69 | 18.26 | 16.98 |
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis